BROWARD HEALTH MEDICAL CENTER
1. Target Overview & Investment Thesis
BROWARD HEALTH MEDICAL CENTER is a 572-bed suburban community hospital in BROWARD, FL with $530.3M in net patient revenue and a -18.4% operating margin. The hospital serves a payer mix of 10.8% Medicare, 13.8% Medicaid, and 75.4% commercial.
Thesis: Undervalued. Our ML models identify $39.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -18.4% to -11.0% (+736bps).
| Net Revenue HCRIS | $530.3M |
| Current EBITDA COMPUTED | $-97.5M |
| Operating Margin COMPUTED | -18.4% |
| Occupancy HCRIS | 67.4% |
| Revenue / Bed COMPUTED | $927K |
| Net-to-Gross HCRIS | 19.0% |
| Distress Probability ML | 46.6% |
2. Market Context & Competitive Position
FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of -18.4% places it below the state median. Among 62 size-comparable peers (286-1144 beds), the median margin is 6.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (286-1144), prioritizing same-state peers. 62 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BROWARD HEALTH MEDICAL CENTER (Target) | FL | 572 | $530.3M | -18.4% |
| UNIVERSITY OF MIAMI HOSP & CLI | FL | 532 | $2.36B | 0.9% |
| UF HEALTH SHANDS | FL | 994 | $2.24B | 10.4% |
| BAPTIST MEDICAL CENTER | FL | 980 | $1.78B | 0.9% |
| TAMPA GENERAL HOSPITAL | FL | 898 | $1.73B | -9.3% |
| BAPTIST HOSPITAL | FL | 948 | $1.71B | 10.8% |
| MEMORIAL REGIONAL HOSPITAL | FL | 838 | $1.45B | -20.7% |
| LEE MEMORIAL HOSPITAL | FL | 748 | $1.28B | 17.4% |
| SARASOTA MEMORIAL HOSPITAL | FL | 787 | $1.10B | 8.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $39.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $11.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $10.6M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $10.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $6.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $339K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-97.5M |
| + RCM Uplift | +$39.0M |
| Pro Forma EBITDA | $-58.5M |
| Current Margin | -18.4% |
| Pro Forma Margin | -11.0% |
| WC Released (1x) | $20.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-150.1M | $-253.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-150.1M | $-327.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-135.1M | $-247.0M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-135.1M | $-309.3M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-165.1M | $-399.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-165.1M | $-493.1M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 62 hospitals with 286-1144 beds
- Same-state prioritization (n=63)
- Comp margins: P25=-5.0% / P50=6.6% / P75=18.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.